| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123214 | Journal of Infection | 2015 | 10 Pages |
Abstract
Serum IL-2, IL-9, IL-13, IL-17, TNF-α, sCD40L and VEGF-A levels may be adjunctive biomarkers for differential diagnosis of active TB, LTBI, and NTM disease. Assessment of serum sCD40L and M. tb antigen-specific IFN-γ, TNF-α, and IL-2 levels could help predict successful anti-TB treatment in conjunction with M. tb clearance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Yun-Gyoung Hur, Young Ae Kang, Sun-Hee Jang, Ji Young Hong, Ahreum Kim, Sang A Lee, Youngmi Kim, Sang-Nae Cho,